Affiliation:
1. Novosibirsk State Medical University;
Research Institute for treatment and preventive medicine, the branch office of «The Federal Research Centre of the Institute of Cytology and Genetics of the Russian Academy of Sciences»
2. Research Institute for treatment and preventive medicine, the branch office of «The Federal Research Centre of the Institute of Cytology and Genetics of the Russian Academy of Sciences»
Abstract
Considering the increasing amount of elderly people in Russia and in the world, an active study of arterial hypertension in this group is an actual and clinically demanded task. The strategic direction defining treatment tactic in such patients, especially over 80 years old, is the determination of their functional status and of the presence of frailty syndrome, which is not synonymous with comorbidity and is not an obligatory early aging companion, but specifies the need for a personalized approach in the treatment of hypertension, even the complete abolition of antihypertensive drugs if needed. The review presents data on the prevalence and clinical features of hypertension in the older age group and presents a digest of the latest European and Russian clinical guidelines about this topic. Special attention is paid to “fragile” patients from the point of view of evidence-based medicine. The influence of different combinations of antihypertensive drugs on cardiovascular events, mortality and cognitive potential is also explained.Aim: To evaluate the functional, cognitive and emotional state of long-livers for determining the amount of necessary assistance from social services and medical personnel.
Publisher
Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology
Reference37 articles.
1. Yoon S.S., Carroll M.D., Fryar C.D. Hypertension Prevalence and Control Among Adults: United States, 2011–2014. NCHS Data Brief. 2015; (220):1–8.
2. Wolf-Maier K., Cooper R.S., Banegas J.R., Giampaoli S., Hense H.W., Joffres M., Kastarinen M., Poulter N., Primatesta P., Rodríguez-Artalejo F., Stegmayr B., Thamm M., Tuomilehto J., Vanuzzo D., Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003; 289(18):2363–9. DOI: 10.1001/jama.289.18.2363.
3. Kotovskaja Ju.V., Kobalava Zh.D. Osobennosti arterial'noj gipertonii v starcheskom vozraste. Consilium Medicum. 2004;12: 888–892. (In Russ.).
4. Grinshtein Yu.I., Petrova M.M., Shabalin V.V., Ruf R.R., Balanova Yu.A., Evstifeeva S.E., Evsyukov A.A., Danilova L.K., Topol’skaya N.V., Kosinova A.A., Shtrikh A.Yu., Shul’min A.V. Rasprostranennost’ arterial’noi gipertenzii v Krasnoyarskom krae po dannym epidemiologicheskogo issledovaniya ESSE-RF. Arterial’naya gipertenziya. 2016;22(6): 551–9. (In Russ.). DOI: 10.18705/1607-419X-2016-22-6-551-559.
5. Imaeva A.E., Shal’nova S.A., Balanova Yu.A., Kapustina A.V., Muromtseva G.A., Evstifeeva S.E., Deev A.D., Shkol’nikov V.M. Vse li traditsionnye faktory riska odinakovo assotsiiruyutsya so smertnost’yu u pozhilogo naseleniya? Kardiovaskulyarnaya terapiya i profilaktika. 2017;16(5):72–75. (In Russ.).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献